18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study

Taralli, Silvia; Sollini, Martina; Milella, Michele; Perotti, Germano; Filice, Angelina; Menga, Massimo; Versari, Annibale; Rufini, Vittoria

doi:10.1186/s13550-018-0423-3

EJNMMI Research

Table 1 Demographic and clinical characteristics of the study population (n = 15)

From: ¹⁸F-FDG and ⁶⁸Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study

Patient	Gender, Age (years)	Site of MCC at diagnosis		MCC stage at diagnosis	Previous surgery for MCC	Previous treatment, time between previous treatment and PET/CT (months)	Associated malignancy	Clinical indication for PET/CT
Patient	Gender, Age (years)	Primary MCC	Unknown primary MCC	MCC stage at diagnosis	Previous surgery for MCC		Associated malignancy	Clinical indication for PET/CT
1	M, 74	Ear		III	Primary tumor excisional biopsy	–	Prostate cancer + chronic lymphocytic leukemia	Staging
2^*	M, 72	Thigh		IV	Surgical excision + lymph node excisional biopsy	CHT (1)	–	Re-staging^#
3	M, 74	Arm		III	Surgical excision + loco-regional lymphadenectomy	CHT (8)	–	Re-staging^§
4	M, 80		Inguinal lymph node	III	Lymph node excisional biopsy	–	Colorectal cancer + cutaneous melanoma	Staging
5	F, 80	Cheek		III	Surgical excision + loco-regional lymphadenectomy	–	Chronic myeloid leukemia	Post-surgical evaluation
6	M, 73	Hand		III	Surgical excision + loco-regional lymphadenectomy	–	–	Re-staging^§
7	M, 47	Cheek		II	Primary tumor excisional biopsy	–	–	Staging
8	M, 71		Inguinal lymph node	III	Lymph node excisional biopsy	CHT (1)	–	Post-CHT evaluation
9	M, 58	Thigh		III	Surgical excision + loco-regional lymphadenectomy	–	–	Post-surgical evaluation
10^*	M, 79	Back		III	Surgical excision + loco-regional lymphadenectomy	CHT (4)	Pancreatic NET	Post-CHT evaluation
11^*	M, 81	Thigh		III	Surgical excision + sentinel lymph node biopsy	RT (10)	Cutaneous melanoma	Re-staging^§
12	F, 41	Gluteus		II	Surgical excision	–	–	Post-surgical evaluation
13	F, 70		Inguinal lymph node	III	Lymph node excisional biopsy	–	–	Staging
14^*	M, 80		Femoral lymph node	III	Lymph node excisional biopsy	RT (72)	–	Re-staging^#
15^*	M, 74	Gluteus		IV	Surgical excision + loco-regional lymphadenectomy	RT (96), CHT (1)	–	Post-CHT evaluation

MCC Merkel cell carcinoma, PET/CT positron emission tomography/computed tomography, M male, F female, CHT chemotherapy, RT radiotherapy
*Patient with recurrent/relapsed MCC
^#For clinical progression
^§For suspected recurrence at imaging

Back to article page